Status:
UNKNOWN
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Lead Sponsor:
State Scientific Centre of Coloproctology, Russian Federation
Conditions:
Colorectal Neoplasms
Intestinal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Currently, the question remains whether palliative primary tumor resection could improve overall survival of minimally symptomatic patients with colorectal cancer and synchronous unresectable metastas...
Detailed Description
The present study is a single-center retrospective observational cohort study with a propensity score matching. Between 2016 and 2022 from our institutional database minimally symptomatic patients wit...
Eligibility Criteria
Inclusion
- Histologically confirmed colorectal adenocarcinoma
- Resectable minimally symptomatic primary tumor with unresectable synchronous metastasis
- Age ≥ 18 years
- Informed consent
Exclusion
- Synchronous cancers
- Carcinomatosis
- Prior surgery, chemotherapy, radiation therapy for the primary tumor or distant metastases
Key Trial Info
Start Date :
October 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05322486
Start Date
October 29 2020
End Date
December 1 2022
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryzhikh National Medical Research Center of Coloproctology
Moscow, Russia